Senate Appropriations Committee approves $164 billion funding bill
By
Lois A. Bowers
Jun 09, 2016
The Senate Appropriations Committee approved a $163.8 billion health and education funding bill Thursday that increases monies for medical research and the fight against opioid abuse, among other areas,...
43 recommendations help fill gap in medical and mental healthcare guidance for assisted living, experts...
By
Lois A. Bowers
Oct 03, 2022
Forty-three recommendations from a new study will guide medical and mental healthcare in assisted living, the authors say.
New state laws emphasize dementia training, background check database access
By
Lois A. Bowers
Jul 22, 2019
S.B. 827 adds dementia training to the continuing education component for physicians and nurses in Connecticut, and S.B. 832 facilitates easier public access to the databases used for background checks...
Signed appropriations package includes $100 million funding increase for dementia research
By
Lois A. Bowers
Mar 25, 2024
A fiscal year 2024 appropriations package signed Saturday by President Biden will increase funding by $100 million for research into Alzheimer’s and other dementias at the National Institutes of Health...
The other drugs that should concern senior living
By
Lois A. Bowers
Oct 28, 2015
Much attention has been paid to reducing the off-label use of antipsychotic medications in older adults, but researchers say the inappropriate use of another class of psychotropic drugs is even more common—and...
Dementia costs jump 31 percent in a decade, with care needs expected to grow
By
Alicia Lasek
Nov 02, 2022
Despite progress in risk reduction, testing and treatment, the costs of dementia care in the United States continue to rise alongside dementia prevalence, putting the onus on healthcare providers and other...
Studies reveal 4 factors in brain health
By
Lois A. Bowers
Mar 14, 2016
Recent research suggests that people can take certain dietary, dental and exercise steps to improve their brain health.
New Alzheimer’s disease drug delivers disappointing results
Jun 17, 2022
The trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition.
Top 10 contributors to health loss in U.S.
By
Lois A. Bowers
Aug 31, 2015
A new analysis contains good and bad news regarding American life expectancy.
FDA gives full approval to Alzheimer’s disease drug Leqembi
Jul 06, 2023
Although Leqembi did help reduce mental decline compared with placebo, the drug has been linked to two deaths from brain bleeds.